• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Personalis, Inc. - Common Stock (NQ:PSNL)

13.62 -0.17 (-1.23%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,782,741
Open 13.97
Bid (Size) 13.50 (200)
Ask (Size) 14.00 (500)
Prev. Close 13.79
Today's Range 13.23 - 14.24
52wk Range 3.840 - 14.18
Shares Outstanding 48,518,901
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Personalis Enables Global Biopharma Support with CE-IVD Marked Specimen Collection Kits
June 09, 2026
From Personalis, Inc.
Via Business Wire
News headline image
Personalis CEO Sells 100,000 Company Shares Worth $1.1 Million. What Does That Mean for Investors? ↗
June 04, 2026
This cancer genomics specialist, serving major biopharma and research clients, reported a notable insider sale in its latest SEC filing. 
Via The Motley Fool
Topics Regulatory Compliance

Performance

YTD
+73.5%
+73.5%
1 Month
+21.0%
+21.0%
3 Month
+107.6%
+107.6%
6 Month
+71.1%
+71.1%
1 Year
+107.3%
+107.3%

More News

Read More
News headline image
Personalis Highlights Early Colorectal Cancer Recurrence Detection and Ultrasensitive MRD Performance Across a Broad Set of Tumor Types at ASCO 2026
June 02, 2026
From Personalis, Inc.
Via Business Wire
News headline image
Personalis to Highlight Breadth of NeXT Personal® Ultra-Sensitive ctDNA Data at ASCO 2026 Annual Meeting, Including Podium Presentation from TRACERx Consortium
May 26, 2026
From Personalis, Inc.
Via Business Wire
Personalis (NASDAQ:PSNL) Volume Surge Can't Mask Q1 Miss as Losses Widen ↗
May 07, 2026
Via Chartmill
Personalis Inc (NASDAQ:PSNL) Reports Mixed Q4 2025 Results and Aggressive 2026 Growth Outlook ↗
February 26, 2026
Via Chartmill
News headline image
Personalis Secures Fourth Medicare Coverage Decision for NeXT Personal®, Expanding Breast Cancer Coverage to Pre-Surgical Treatment Monitoring
May 20, 2026
From Personalis, Inc.
Via Business Wire
News headline image
Personalis to Participate in Upcoming Investor Events
May 14, 2026
From Personalis, Inc.
Via Business Wire
News headline image
Personalis Receives Medicare Coverage for NeXT Personal® for Immunotherapy Monitoring Across Late-stage Solid Tumors
May 13, 2026
From Personalis, Inc.
Via Business Wire
News headline image
Personalis Q1 Earnings Call Highlights ↗
May 08, 2026
Via MarketBeat
Topics Earnings
News headline image
Personalis (PSNL) Q1 2026 Earnings Transcript ↗
May 08, 2026
Via The Motley Fool
News headline image
Personalis Reports First Quarter Results and Recent Highlights
May 07, 2026
From Personalis, Inc.
Via Business Wire
News headline image
Personalis to Announce First Quarter 2026 Financial Results
April 23, 2026
From Personalis, Inc.
Via Business Wire
News headline image
Personalis Highlights Clinical Impact of Ultrasensitive ctDNA Monitoring and New Therapy Resistance Tracking at AACR 2026
April 21, 2026
From Personalis, Inc.
Via Business Wire
News headline image
Personalis and Collaborators to Highlight Ultrasensitive ctDNA Data and New Therapy Resistance Tracking Capabilities at AACR 2026
April 13, 2026
From Personalis, Inc.
Via Business Wire
News headline image
Personalis to Participate in the 25th Annual Needham Virtual Conference
April 01, 2026
From Personalis, Inc.
Via Business Wire
News headline image
Personalis Appoints Dr. Richard Chen as President to Further Accelerate MRD Adoption
March 17, 2026
From Personalis, Inc.
Via Business Wire
News headline image
Personalis Announces New Publication Advancing Neoadjuvant Treatment Monitoring in Breast Cancer with NeXT Personal®
March 12, 2026
From Personalis, Inc.
Via Business Wire
News headline image
Lightspeed Makes a Big Bet on Self-Driving Trucks, Loading Up on 7 Million Shares of Kodiak AI (KDK) ↗
March 01, 2026
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Lightspeed Management Made a Huge Bet on Navan (NAVN) With a Purchase of 49.9 Million Shares ↗
March 01, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Personalis (PSNL) Q4 2025 Earnings Call Transcript ↗
February 26, 2026
Via The Motley Fool
Topics Earnings
Wondering what's happening in today's after-hours session? ↗
February 26, 2026
Via Chartmill
News headline image
Personalis Reports Fourth Quarter and Full Year 2025 Results and Recent Highlights
February 26, 2026
From Personalis, Inc.
Via Business Wire
News headline image
Personalis to Participate in the TD Cowen 46th Annual Healthcare Conference
February 17, 2026
From Personalis, Inc.
Via Business Wire
News headline image
Personalis to Announce Fourth Quarter and Full Year 2025 Financial Results
February 12, 2026
From Personalis, Inc.
Via Business Wire

Frequently Asked Questions

Is Personalis, Inc. - Common Stock publicly traded?
Yes, Personalis, Inc. - Common Stock is publicly traded.
What exchange does Personalis, Inc. - Common Stock trade on?
Personalis, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Personalis, Inc. - Common Stock?
The ticker symbol for Personalis, Inc. - Common Stock is PSNL on the Nasdaq Stock Market
What is the current price of Personalis, Inc. - Common Stock?
The current price of Personalis, Inc. - Common Stock is 13.62
When was Personalis, Inc. - Common Stock last traded?
The last trade of Personalis, Inc. - Common Stock was at 07/02/26 04:00 PM ET
What is the market capitalization of Personalis, Inc. - Common Stock?
The market capitalization of Personalis, Inc. - Common Stock is 660.83M
How many shares of Personalis, Inc. - Common Stock are outstanding?
Personalis, Inc. - Common Stock has 661M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap